Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Clasificación en acciones #27535
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Precio por acción
$0.0416118
Capitalización bursátil
$32.25M
Cambio (1 día)
-1.67%
Cambio (1 año)
-59.58%
País
AU
Comercio Neurizon Therapeutics Limited (NUZ)

Categoría

Historial de desdoblamientos de acciones de Neurizon Therapeutics Limited (NUZ)
La acción Neurizon Therapeutics Limited (símbolo: NUZ) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 20, 2026.
Una acción NUZ comprada antes de Aug 20, 2026 equivaldría hoy a 0 acciones NUZ.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH